Patient-reported outcomes of parenteral somatostatin analogue injections in 195 patients with acromegaly.
This work is licensed under a Creative Commons Attribution 3.0 Unported License ; BACKGROUND: Long-acting somatostatin analogues delivered parenterally are the most widely used medical treatment in acromegaly. This patient-reported outcomes survey was designed to assess the impact of chronic injections on subjects with acromegaly. METHODS: The survey was conducted in nine pituitary centres in Germany, UK and The Netherlands. The questionnaire was developed by endocrinologists and covered aspects of acromegaly symptoms, injection-related manifestations, emotional and daily life impact, treatmen... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2016 |
Schlagwörter: | Acromegaly / Adenoma / Adult / Aged / 80 and over / Antineoplastic Agents / Hormonal / Cost of Illness / Delayed-Action Preparations / Female / Germany / Growth Hormone-Secreting Pituitary Adenoma / Humans / Injections / Intramuscular / Subcutaneous / Male / Middle Aged / Netherlands / Octreotide / Patient Outcome Assessment / Patient Satisfaction / Peptides / Cyclic / Self Report / Somatostatin / Surveys and Questionnaires / Treatment Outcome / Young Adult |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-28771495 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://qmro.qmul.ac.uk/xmlui/handle/123456789/12718 |